NCT03393390

Brief Summary

The purpose of this study is to learn more about the functioning of particular types of regions of the brain, specifically, those related to externalizing disorders such as Attention Deficit Hyperactivity Disorder (ADHD), Oppositional Defiance Disorder (ODD), and Conduct Disorder (CD). Brain function of children and adolescents with externalizing disorders such as ADHD, ODD, and CD will be compared to the brain function of those without. Functional Magnetic Resonance Imaging (fMRI) will be used to monitor brain activity at work and at resting states.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
256

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 17, 2016

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

December 20, 2017

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 8, 2018

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
Last Updated

April 14, 2022

Status Verified

April 1, 2022

Enrollment Period

3.5 years

First QC Date

December 20, 2017

Last Update Submit

April 6, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Maturation Curves for regulatory control structures in brain

    Resting state fMRI functional connectivity maps will be used to generate normative growth curves for each component in the brain's regulatory control architecture using a multi-level linear mixed effects model. Each individual's deviation from their expected growth (based on the normative growth chart) is calculated and is utilized to predict clinical outcome variables.

    Single fMRI session lasting no more than 2 hours

Study Arms (2)

Healthy Controls

Subjects in this group will be defined as healthy controls after meeting with a clinician and determining that they do not meet the diagnostic criteria for any externalizing disorders or other psychiatric disorders.

Diagnostic Test: Clinical Assessment VisitOther: fMRI scan

Externalizing

Subjects in this group will be defined as externalizing if the clinician determines that they meet the diagnostic criteria for one or more externalizing disorders, such as ADHD, ODD, or CD.

Diagnostic Test: Clinical Assessment VisitOther: fMRI scan

Interventions

Subjects will meet with a clinician who will determine if they meet diagnostic criteria for an externalizing disorder.

ExternalizingHealthy Controls

Subjects will undergo an fMRI scan where images will be taken for observational purposes only, not as a means of diagnosis.

ExternalizingHealthy Controls

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Community sample, clinic patients.

You may qualify if:

  • The healthy control group will be made up of approximately 135 subjects between the ages of 6-18 at the start of the study who meet no diagnostic criteria for any externalizing disorders.
  • The externalizing group will be made up of approximately 135 subjects between the ages of 6-18 at the start of the study who meet the diagnostic criteria for at least one externalizing disorder (ADHD, ODD, CD, etc)

You may not qualify if:

  • IQ below 80
  • History of significant head injury (e.g. loss of consciousness greater than 5 minutes, report of skull fracture or cerebral hemorrhage, or hospitalization)
  • Presence of any significant medical or neurological condition that might impact activity in the neural circuits of interest or that might increase risk of participation for the subject (e.g. seizure disorder or mass lesions)
  • Contraindications to MRI (e.g. metal objects in body, claustrophobia)
  • Abnormal vision after correction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Attention Deficit Disorder with HyperactivityOppositional Defiant DisorderConduct Disorder

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Officials

  • Chandra Sripada, PhD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Psychiatry and Philosophy

Study Record Dates

First Submitted

December 20, 2017

First Posted

January 8, 2018

Study Start

March 17, 2016

Primary Completion

September 1, 2019

Study Completion

September 1, 2019

Last Updated

April 14, 2022

Record last verified: 2022-04

Locations